PRESS RELEASE published on 03/04/2025 at 08:35, 1 year ago AB Science: Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch AB Science's masitinib and its phase 3 principal investigator, neurologist Patrick Vermersch, featured in Life Sciences Magazine for potential breakthrough in Progressive MS Treatment AB Science Masitinib Patrick Vermersch Life Sciences Magazine Progressive MS Treatment
BRIEF published on 01/29/2025 at 19:08, 1 year 2 months ago AB Science Updates on Masitinib Platform Progress Multiple Sclerosis Masitinib Platform ALS Study Alzheimer’s Treatment AB Science Strategy
PRESS RELEASE published on 01/29/2025 at 19:03, 1 year 2 months ago AB Science today provides an update on its masitinib platform AB Science provides update on masitinib platform for ALS, MS, and AD. Positive results show potential for huge market sales. Debt negotiation planned Update AB Science Masitinib Platform Market Sales Debt Negotiation
BRIEF published on 01/24/2025 at 18:06, 1 year 2 months ago AB Science to Present Masitinib Update in Upcoming Webcast Pharmaceuticals Webcast Research Update AB Science Masitinib
PRESS RELEASE published on 01/24/2025 at 18:01, 1 year 2 months ago AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET AB Science to host live webcast on masitinib platform update on January 28, 2025, 5.30pm CET. Leading pharmaceutical company specializing in protein kinase inhibitors Pharmaceutical Company Live Webcast AB Science Protein Kinase Inhibitors Masitinib Platform
BRIEF published on 01/22/2025 at 19:04, 1 year 2 months ago AB Science Participates in Biomed Forum Investors Conference Investor Conference BIOMED Forum AB Science Masitinib Protein Kinase Inhibitors
PRESS RELEASE published on 01/22/2025 at 18:59, 1 year 2 months ago AB Science will participate in the Biomed Forum investors conference AB Science to participate in Biomed Forum Investors Conference organized by AllInvest Securities in Paris on February 4, 2025 Pharmaceutical Company BIOMED Forum AB Science Investors Conference AllInvest Securities
BRIEF published on 12/17/2024 at 19:09, 1 year 3 months ago AB Science presents the advances of AB8939 for acute myeloid leukemia Phase 1 AB8939 Acute Myeloid Leukemia Drug Resistance Potential Market
PRESS RELEASE published on 12/17/2024 at 19:04, 1 year 3 months ago AB Science provides a summary of the webcast held on December 16, 2024 AB Science provides an update on AB8939, a novel microtubule destabilizer and ALDH inhibitor in phase 1 for AML treatment. Potential market size exceeded EUR 2 billion per annum Market Potential AML Treatment AB Science Phase 1 AB8939
BRIEF published on 10/17/2024 at 19:33, 1 year 5 months ago AB Science Faces Setback in EMA Approval for ALS Treatment AB Science Masitinib Marketing Authorization ALS Treatment EMA Decision
Published on 03/29/2026 at 12:15, 8 hours 1 minute ago China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 1 day 18 hours ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 18 hours ago Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:45, 1 day 20 hours ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/29/2026 at 17:05, 3 hours 10 minutes ago FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR
Published on 03/28/2026 at 10:05, 1 day 10 hours ago Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 11 hours ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 17 hours ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 21 hours ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 18:52, 2 days 1 hour ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 2 days 1 hour ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 2 days 2 hours ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 2 days 2 hours ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
